SUBSCRIBE
SUBSCRIBE
News   Drug Development

Dendreon Corporation Soars on Plans to Present Prostate Study

April 3, 2009 | 
1 min read

Bloomberg -- Dendreon Corp. rose the most in two years in Nasdaq trading after the company reserved conference space to present data on its prostate cancer drug later this month.

Clinical research Phase III
MORE ON THIS TOPIC
2D illustration of the gut with microorganisms
Inflammatory bowel disease
Lilly and J&J Face Off in Crohn’s Disease With Phase III Readouts at ACG 2024
October 29, 2024
 · 
2 min read
 · 
Tristan Manalac
Psychological concept. Chaotic thought process
Business
AbbVie Doubles Down on Alzheimer’s With $1.4B Aliada Buy
October 28, 2024
 · 
2 min read
 · 
Heather McKenzie
3D Illustration of a pancreas with tumors
Pancreatic cancer
Revolution Medicines Targets Hard-to-Treat Pancreatic Cancer With Two Early-Phase Readouts
October 28, 2024
 · 
2 min read
 · 
Tristan Manalac
2D illustration of kidneys
IgA nephropathy
Biogen, Vertex Heat Up IgAN Arena With Mid-Stage Readouts at ASN 2024
October 28, 2024
 · 
3 min read
 · 
Tristan Manalac